new york times semaglutide Opinion | GLP-1 Experimentation Is Everywhere, and Science Can't Keep Up Recently I was interviewed by
Description
Weight loss isn't linear
Weight (morning, after bathroom, before eating): Daily weight fluctuates wildly based on water, sodium, hormones, and bowel movements
When the semaglutide medication Wegovy first hit the market in 2021, it became the first weight-loss drug to get FDA approval since 2014 and immediately became the go-to weight-loss treatment
Ethics declarations Competing interests K.L.J
If this sounds like your situation, you should know youre not the only one
2026 (Frontiers in Endocrinology) Review of managing nausea and vomiting in GLP-1-based obesity therapies
